Our results add to the body of evidence [62, 137] suggesting that expression of different H19 isoforms in cancer may be regulated by different mechanisms, some of which lead to LOI and biallelic isoform expression, whereas others may upregulate monoallelically expressed isoforms. Here, H19 is linked to cancer.